Disease-modifying therapies for multiple sclerosis. EBSCO DynaMed Plus website. Available at:http://www.dynamed.com/topics/dmp~AN~T905968/Disease-modifying-therapies-for-multiple-sclerosis. Updated August 10, 2018. Accessed September 26, 2018.
Goodin DS, Frohman EM, et al. Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines. Neurology. 2002 Jan 22;58(2):169-178.
Multiple sclerosis (MS). EBSCO DynaMed Plus website. Available at:https://www.dynamed.com/topics/dmp~AN~T116285/Multiple-sclerosis-MS. Updated July 23, 2018. Accessed September 26, 2018.
NINDS multiple sclerosis information page. National Institute of Neurological Disorders and Stroke website. Available at: https://www.ninds.nih.gov/Disorders/All-Disorders/Multiple-Sclerosis-Information-Page. Accessed September 27, 2018.
Plasmapheresis. Johns Hopkins Medicine website. Available at: http://www.hopkinsmedicine.org/transplant/programs/kidney/incompatible/plasmapheresis.html. Accessed September 26, 2018.
Treatment of specific impairments in multiple sclerosis. EBSCO DynaMed Plus website. Available at:http://www.dynamed.com/topics/dmp~AN~T905969/Treatment-of-specific-impairments-in-multiple-sclerosis. Updated April 20, 2018. Accessed September 26, 2018.
2/18/2011 DynaMed Plus Systematic Literature Surveillancehttp://www.dynamed.com/topics/dmp~AN~T113820/Antidepressant-medication-overview: Serretti A, Mandelli L. Antidepressants and body weight: a comprehensive review and meta-analysis. J Clin Psychiatry. 2010;71(10):1259-1272.